[TVTX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 276.03%
YoY- 316.40%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 62,898 37,095 53,496 68,217 51,139 44,373 40,706 7.51%
PBT -54,836 -89,229 -69,511 -35,596 -22,526 -37,013 -54,101 0.22%
Tax -84 -12 145 43 23 -523 415 -
NP -54,811 150,735 -69,656 -35,639 -22,549 -36,490 -54,516 0.08%
Tax Rate - - - - - - - -
Total Cost 117,709 -113,640 123,152 103,856 73,688 80,863 95,222 3.59%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -87.14 406.35 -130.21 -52.24 -44.09 -82.23 -133.93 -6.90%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.70 -0.99 -1.09 -0.59 -0.44 -0.85 -1.34 -10.24%
EPS Diluted -0.70 -0.99 -1.09 -0.59 -0.44 -0.85 -1.34 -10.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.